NASOPHARYNGEAL CANCER—Five-Year Results of Treatment with Intracavitary Cobalt60
Jerome M. Vaeth and Franz Buschke Seven of twenty-two patients treated with intracavitary Co60 therapy for nasopharyngeal neoplasms remained controlled for more than five years. No patient treated with intracavitary Co60 therapy alone has remained alive. Of the seven surviving patients, four received...
